10-Nitrooleate-d17 Reference: 10558-500 An internal standard for the quantification of arachidonic acid by GC- or LC-MS
Fenofibrate Reference: 10005368-50 A PPARα agonist (EC50s = 18 and 30 μM for mouse and human receptors, respectively, in a transactivation assay); selective for PPARα over PPARγ (EC50s = 300 and 200 μM for mouse and human receptors, respectively) and lacks activity at mouse and human PPARδ at 100 μM; reduces plasma levels of triglycerides, C-reactive protein, and MDA in mice with fructose-induced hypertriglycemia from 50-100 mg/kg; decreases cisplatin-induced glomerular and tubular atrophy and necrosis in rat kidney at 100 mg/kg; reduces the number of 4-NQO-induced pulmonary lesions in lung in TSOD mice
Decitabine (NSC127716, 5AZA-CdR) Reference: A1906-50 Deoxycytidine analog and cellular diifferentiation inducer
Heneicosapentaenoic Acid-d6 Reference: 10570-100 An internal standard for the quantification of HPA by GC- or LC-MS
Orlistat Reference: 10005426-100 An anti-obesity drug that inhibits gastric, pancreatic, and carboxyl ester lipases, preventing hydrolysis of triglycerides to free fatty acids and monoglycerides; potently inhibits human recombinant DAGLα (IC50 = 60 nM) and at 1 µM inhibits the formation of 2-AG in intact cells
Heneicosapentaenoic Acid-d6 Reference: 10570-25 An internal standard for the quantification of HPA by GC- or LC-MS
Orlistat Reference: 10005426-250 An anti-obesity drug that inhibits gastric, pancreatic, and carboxyl ester lipases, preventing hydrolysis of triglycerides to free fatty acids and monoglycerides; potently inhibits human recombinant DAGLα (IC50 = 60 nM) and at 1 µM inhibits the formation of 2-AG in intact cells